Subcutaneous Biologics Market, Industry Trends and Global Forecasts to 2035: Subcutaneous Biologics Set to Transform Drug Delivery and Patient Adherence
January 16, 2025 07:13 ET
|
Research and Markets
Dublin, Jan. 16, 2025 (GLOBE NEWSWIRE) -- The "Subcutaneous Biologics Market, Industry Trends and Global Forecasts to 2035: Type of Biologic, Type of Therapy, Method of Administration, Fundamental...
Connected Drug Delivery Devices Research Report 2024: Global Market to Reach $22.9 Billion by 2030 Growing at a CAGR of 21.7%, Driven by Rising Focus on Personalized Medicine and Wearable Tech
January 09, 2025 04:17 ET
|
Research and Markets
Dublin, Jan. 09, 2025 (GLOBE NEWSWIRE) -- The "Connected Drug Delivery Devices - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for...
Subcutaneous Drug Delivery Devices (Prefilled Syringes, Pen Injectors) Market Trends Analysis Report, 2025-2030 - Increasing Focus on Self-administration and Prevention of Dosing Errors Bolster Growth
November 19, 2024 11:40 ET
|
Research and Markets
Dublin, Nov. 19, 2024 (GLOBE NEWSWIRE) -- The "Subcutaneous Drug Delivery Devices Market Size, Share & Trends Analysis Report by Product (Prefilled Syringes, Pen Injectors), Distribution Channel...
Global Drug Device Combination Products Market 2024-2030: Trends and Growth Opportunities for Transdermal Patches, Infusion Pumps, Inhalers, and Drug Eluting Stents
June 18, 2024 11:12 ET
|
Research and Markets
Dublin, June 18, 2024 (GLOBE NEWSWIRE) -- The "Global Drug Device Combination Products Market Size, Share & Trends Analysis Report by Product (Transdermal Patches, Infusion Pumps, Inhalers, Drug...
Drug Device Combination Products Market Worth Over $180 Billion by 2029 - Medtronic, Abbott Laboratories, and Boston Scientific Corporation Dominate the Industry
May 10, 2024 05:06 ET
|
Research and Markets
Dublin, May 10, 2024 (GLOBE NEWSWIRE) -- The "Drug Device Combination Products Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F" report has been added to ...
Global Drug and Gene Delivery Devices Market Worth $430.25 Billion in 2023 Projected to Reach $956.20 Billion by 2034 - Luxturna and Yescarta Anticipated to Lead Commercialized Drug Segments
January 25, 2024 11:22 ET
|
Research and Markets
Dublin, Jan. 25, 2024 (GLOBE NEWSWIRE) -- The "Global Drug And Gene Delivery Devices Market Analysis & Forecast to 2024-2034" report has been added to ResearchAndMarkets.com's offering. ...
Global Needle-Free Drug Delivery Devices Market Analysis, 2024-2034, Dominated by PharmaJet, Halozyme (Antares Pharma), Crossject, 3M, and PenJet Corporation
January 24, 2024 14:17 ET
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Global Needle-Free Drug Delivery Devices Market Analysis & Forecast 2024-2034" report has been added to ResearchAndMarkets.com's offering. The...
Global Topical Drug Delivery Market Report 2023: Increasing Self-Administration and Home Care Presents Opportunities
April 11, 2023 08:13 ET
|
Research and Markets
Dublin, April 11, 2023 (GLOBE NEWSWIRE) -- The "Global Topical Drug Delivery Market (2023-2028) by Products, Routes of Administration, End-User, and Geography, Competitive Analysis, Impact of...
Global Connected Drug Delivery Devices Market Insights 2023-2028: Rising Awareness Regarding Self-administered Therapy and Increased Patient Connectivity and Engagement
April 04, 2023 10:08 ET
|
Research and Markets
Dublin, April 04, 2023 (GLOBE NEWSWIRE) -- The "Connected Drug Delivery Devices - Market Insights, Competitive Landscape, and Market Forecast - 2028" report has been added to ...
World Repositioning IV Therapeutics Delivery Systems Market Research Report 2021: Drug Delivery Device Evolution, The Trend Toward Patient Self-Administration, & Lyophilized Drugs/Reconstitution
February 08, 2022 05:38 ET
|
Research and Markets
Dublin, Feb. 08, 2022 (GLOBE NEWSWIRE) -- The "Delivery Systems for Repositioning IV Therapeutics" report has been added to ResearchAndMarkets.com's offering. As currently formulated, a...